OTC

Strength

1; 5; 2.5 mg/5mL; mg/5mL; mg/5mL

NDC

00485020416

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

4/22/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

3/14/2011

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

+6.0%

3M

+4.1%

6M

+1.4%

1Y

+11.5%

3Y

+14.5%

5Y

+23.4%

All

+47.7%